Protagonist Therapeutics
PTGX
#3342
Rank
โ‚ฌ3.05 B
Marketcap
49,70ย โ‚ฌ
Share price
-1.30%
Change (1 day)
80.29%
Change (1 year)

EPS for Protagonist Therapeutics (PTGX)

EPS in 2023 (TTM): -2,53ย โ‚ฌ

According to Protagonist Therapeutics 's latest financial reports the company's current EPS (TTM) is -2,46ย โ‚ฌ. In 2022 the company made an earnings per share (EPS) of -2,38ย โ‚ฌ an increase over its 2021 EPS that were of -2,48ย โ‚ฌ.

EPS history for Protagonist Therapeutics from 2015 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-2,53ย โ‚ฌ6.28%
2022-2,38ย โ‚ฌ-3.7%
2021-2,48ย โ‚ฌ35%
2020-1,83ย โ‚ฌ-33.33%
2019-2,75ย โ‚ฌ74.42%
2018-1,58ย โ‚ฌ-20.74%
2017-1,99ย โ‚ฌ-45.64%
2016-3,66ย โ‚ฌ57.3%
2015-2,33ย โ‚ฌ

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
-2,00ย โ‚ฌ-18.66%๐Ÿ‡บ๐Ÿ‡ธ USA